首页> 外文期刊>Journal of combinatorial chemistry >A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases
【24h】

A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases

机译:设计用于药物发现的组合或药物化学图书馆的基于知识的方法。 1.已知药物数据库的定性和定量表征

获取原文
获取原文并翻译 | 示例
           

摘要

The discovery of various protein/receptor targets from genomic research is expanding rapidly. Along with the automation of organic synthesis and biochemical screening, this is bringing a major change in the whole field of drug discovery research. In the traditional drug discovery process, the industry tests compounds in the thousands. With automated synthesis, the number of compounds to be tested could be in the millions. This two-dimensional expansion will lead to a major demand for resources, unless the chemical libraries are made wisely. The objective of this work is to provide both quantitative and qualitative characterization of known drugs which will help to generate "drug-like" libraries. In this work we analyzed the Comprehensive Medicinal Chemistry (CMC) database and seven different subsets belonging to different classes of drug molecules. These include some central nervous system active drugs and cardiovascular, cancer, inflammation, and infection disease states. A quantitative characterization based on computed physicochemical property profiles such as log P, molar refractivity, molecular weight, and number of atoms as well as a qualitative characterization based on the occurrence of functional groups and important substructures are developed here. For the CMC database, the qualifying range (covering more than 80% of the compounds) of the calculated log P is between -0.4 and 5.6, with an average value of 2.52. For molecular weight, the qualifying range is between 160 and 480, with an average value of 357. For molar refractivity, the qualifying range is between 40 and 130, with an average value of 97. For the total number of atoms, the qualifying range is between 20 and 70, with an average value of 48. Benzene is by far the most abundant substructure in this drug database, slightly more abundant than all the heterocyclic rings combined. Nonaromatic heterocyclic rings are twice as abundant as the aromatic heterocycles. Tertiary aliphatic amines, alcoholic OH and carboxamides are the most abundant functional groups in the drug database. The effective range of physicochemical properties presented here can be used in the design of drug-like combinatorial libraries as well as in developing a more efficient corporate medicinal chemistry library.
机译:来自基因组研究的各种蛋白质/受体靶标的发现正在迅速扩展。随着有机合成和生化筛选的自动化,这在整个药物发现研究领域带来了重大变化。在传统的药物发现过程中,该行业对数千种化合物进行测试。通过自动合成,要测试的化合物数量可以达到数百万。除非化学库设计得当,否则这种二维扩展将导致对资源的主要需求。这项工作的目的是提供已知药物的定量和定性表征,这将有助于生成“类药物”文库。在这项工作中,我们分析了综合药物化学(CMC)数据库以及属于不同类别药物分子的七个不同子集。其中包括一些中枢神经系统活性药物以及心血管,癌症,炎症和感染性疾病。在此开发了基于计算的理化性质分布(例如log P,摩尔折射率,分子量和原子数)的定量表征,以及基于官能团和重要亚结构的出现的定性表征。对于CMC数据库,计算出的log P的合格范围(涵盖80%以上的化合物)在-0.4至5.6之间,平均值为2.52。对于分子量,合格范围在160到480之间,平均值为357。对于摩尔折射率,合格范围在40到130之间,平均值为97。对于原子总数,合格范围在20至70之间,平均值为48。苯是该药物数据库中最丰富的亚结构,比所有杂环的总和稍丰富。非芳族杂环是芳族杂环的两倍。脂族叔胺,醇羟基和羧酰胺是药物数据库中最丰富的官能团。本文介绍的理化性质的有效范围可用于设计类似药物的组合库,以及用于开发更有效的公司药物化学库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号